News

    News


    All GHI News

    • UniverCity Year program to partner with six communities in 2022

      Now in its seventh year, University of Wisconsin-Madison’s UniverCity Year program is working with six communities stretching from the neighboring City of Stoughton to Polk County in northwest Wisconsin. UniverCity Year (UCY) is the hallmark program of UniverCity Alliance–an initiative that connects local governments across Wisconsin with resources at the university. Through the three-year UCY…

    • 2022 Global Health Symposium is April 19

      2022 Global Health Symposium is April 19

      April 19: The 2022 Global Health Symposium, “Making Connections: Health, Climate & Equity,” includes a keynote address from Jalonne White-Newsome on advancing climate justice, a panel that introduces the U.N. Sustainable Development goals, posters from across campus and a reception.

    • Finalists named for GHI Director position

      Finalists named for GHI Director position

      Watch the presentations from the four finalists for the GHI Director position.

    • Gregg Mitman’s new book highlights land use, racial injustice, and America’s shared history with Liberia

      Gregg Mitman’s new book highlights land use, racial injustice, and America’s shared history with Liberia

      Nearly 6,000 miles separates the United States and the West African country of Liberia, but their histories are forever intertwined. In fact, Nelson Institute affiliate Gregg Mitman, who also serves as the Vilas Research and William Coleman Professor of History of Science, Medical History, and Environmental Studies at the University of Wisconsin-Madison, says that to…

    • Current anti-COVID pills work well against omicron, but antibody drugs are less effective

      The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab tests also showed that the available antibody therapies — typically given intravenously in hospitals — are substantially less effective against omicron than against earlier variants of…